We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
BrightView Holdings
BV
$1.33B
| $493K | ﹤0.01% |
62,089
-1,835,295
| -97% | -$19.6M |
|
602
Medifast
MED
$110M
| $493K | ﹤0.01% |
4,548
+1,396
| +44% | +$200K |
|
603
Ternium
TX
$9.37B
| $493K | ﹤0.01% |
18,002
+359
| +2% | +$11.5K |
|
|
LSEA
604
DELISTED
Landsea Homes
LSEA
| $492K | ﹤0.01% |
103,200
+20,692
| +25% | +$135K |
|
605
The Joint Corp
JYNT
$122M
| $490K | ﹤0.01% |
31,184
+12,144
| +64% | +$216K |
|
|
ATSG
606
DELISTED
Air Transport Services Group
ATSG
| $486K | ﹤0.01% |
+20,187
| New | +$586K |
|
607
Spire
SR
$4.87B
| $485K | ﹤0.01% |
+7,780
| New | +$556K |
|
608
Oil States International
OIS
$512M
| $480K | ﹤0.01% |
123,353
+54,195
| +78% | +$259K |
|
609
Crawford & Co Class A
CRD.A
$545M
| $478K | ﹤0.01% |
83,223
+14,024
| +20% | +$93.6K |
|
610
Kelly Services Class A
KELYA
$545M
| $477K | ﹤0.01% |
35,131
+704
| +2% | +$12.7K |
|
611
American Express Global Business Travel
GBTG
$4.91B
| $474K | ﹤0.01% |
83,795
+1,712
| +2% | +$11.5K |
|
612
JFrog
FROG
$9.84B
| $466K | ﹤0.01% |
21,083
+1,528
| +8% | +$34K |
|
613
Radcom
RDCM
$222M
| $461K | ﹤0.01% |
40,448
+445
| +1% | +$5.2K |
|
614
Barnes & Noble Education
BNED
$445M
| $458K | ﹤0.01% |
1,910
+788
| +70% | +$211K |
|
615
Stoneridge
SRI
$210M
| $450K | ﹤0.01% |
26,565
+1,898
| +8% | +$35.7K |
|
616
Civista Bancshares
CIVB
$595M
| $445K | ﹤0.01% |
21,439
+236
| +1% | +$5.08K |
|
617
Dole
DOLE
$1.34B
| $440K | ﹤0.01% |
60,220
-3,982
| -6% | -$35.4K |
|
618
Asure Software
ASUR
$222M
| $438K | ﹤0.01% |
76,491
+18,203
| +31% | +$99.5K |
|
619
Natural Gas Services Group
NGS
$469M
| $435K | ﹤0.01% |
43,308
+476
| +1% | +$4.89K |
|
620
Liberty Energy
LBRT
$2.75B
| $434K | ﹤0.01% |
34,195
-46,349
| -58% | -$626K |
|
621
O-I Glass
OI
$1.41B
| $433K | ﹤0.01% |
33,428
+9,350
| +39% | +$127K |
|
622
Carpenter Technology
CRS
$28.8B
| $429K | ﹤0.01% |
13,784
+2,411
| +21% | +$79.7K |
|
623
Kaltura
KLTR
$220M
| $429K | ﹤0.01% |
195,166
-170,411
| -47% | -$385K |
|
624
First Bancorp
FBP
$4.39B
| $424K | ﹤0.01% |
+31,024
| New | +$450K |
|
625
Vanguard Value ETF
VTV
$189B
| $422K | ﹤0.01% |
3,368
-9,820
| -74% | -$1.33M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.